Boehringer Ingelheim has chosen ChemAxon’s chemistry software platform for multiple applications across research and development, supporting in-house activities and work with external collaboration partners. ChemAxon technology will be used to store, search, calculate, and visualize chemical entities, properties, and reactions. The goal is to help streamline the progression from drug discovery to clinical candidate. ChemAxon was chosen after an extensive evaluation process that built on dimensions such as ROI, performance, robustness, scalability, and future development roadmap.
Last year, Eisai licensed ChemAxon’s JChem Cartridge for Oracle product. The database storage and search technology is being used by Eisai for the management of chemical structure information generated in discovery processes in Eisai’s global R&D organization.